CN Stock MarketDetailed Quotes

002262 Jiangsu Nhwa Pharmaceutical

Watchlist
  • 24.62
  • -0.18-0.73%
Market Closed Dec 20 15:00 CST
25.02BMarket Cap21.35P/E (TTM)

Jiangsu Nhwa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
12.01%4.46B
11.83%2.89B
5.39%1.44B
12.78%5.3B
17.32%3.98B
17.49%2.58B
20.51%1.36B
12.89%4.7B
7.39%3.39B
6.88%2.2B
Refunds of taxes and levies
525.40%101.94K
245.16%56.26K
41.91%19.87K
-92.69%21.06K
-75.88%16.3K
-63.58%16.3K
-68.72%14K
-66.58%288.22K
-92.38%67.57K
-84.73%44.76K
Cash received relating to other operating activities
19.66%87.89M
17.00%60.79M
45.58%28.41M
-5.15%92.29M
49.48%73.45M
55.17%51.95M
23.94%19.52M
46.39%97.3M
83.74%49.14M
31.42%33.48M
Cash inflows from operating activities
12.15%4.55B
11.94%2.95B
5.95%1.47B
12.41%5.39B
17.77%4.06B
18.06%2.63B
20.55%1.38B
13.40%4.8B
8.01%3.44B
7.17%2.23B
Goods services cash paid
20.06%1.06B
2.77%621.53M
15.25%343.92M
8.26%1.15B
12.25%880.33M
19.18%604.75M
8.68%298.42M
31.81%1.06B
1.12%784.29M
5.59%507.42M
Staff behalf paid
4.99%765.4M
7.35%451.4M
11.51%222.22M
13.00%940.48M
15.61%728.99M
22.39%420.48M
15.24%199.29M
10.89%832.26M
19.70%630.55M
28.01%343.55M
All taxes paid
10.29%554.69M
11.55%397.27M
32.63%208.32M
24.70%677.63M
19.57%502.94M
18.86%356.15M
34.28%157.07M
-0.49%543.39M
0.61%420.64M
-1.91%299.63M
Cash paid relating to other operating activities
12.06%1.26B
6.13%856.2M
25.64%458.35M
7.85%1.62B
16.21%1.12B
17.78%806.76M
22.69%364.82M
5.04%1.5B
3.06%967.93M
-1.99%684.96M
Cash outflows from operating activities
12.37%3.64B
6.32%2.33B
20.91%1.23B
11.38%4.38B
15.47%3.24B
19.21%2.19B
18.30%1.02B
11.53%3.94B
5.40%2.8B
4.69%1.84B
Net cash flows from operating activities
11.30%911.19M
39.51%621.84M
-35.90%233.58M
17.10%1.01B
27.86%818.65M
12.72%445.74M
27.34%364.4M
22.81%861.02M
21.11%640.26M
20.36%395.46M
Investing cash flow
Cash received from returns on investments
15.24%37.37M
-26.35%17.42M
-40.80%6.73M
30.56%42.25M
29.21%32.43M
61.03%23.66M
136.73%11.36M
-6.18%32.36M
4.83%25.1M
-15.43%14.69M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
15.04%603.82K
-55.76%143.71K
----
1,532.73%1.48M
1,271.31%524.88K
--324.88K
--189.88K
-73.61%90.8K
-88.95%38.28K
----
Cash received relating to other investing activities
-1.70%4.69B
-37.65%2.47B
-46.60%1.01B
26.42%6.49B
17.46%4.77B
47.23%3.96B
65.32%1.88B
40.89%5.13B
81.22%4.06B
75.14%2.69B
Cash inflows from investing activities
-1.58%4.72B
-37.58%2.49B
-46.57%1.01B
26.48%6.53B
17.54%4.8B
47.31%3.98B
65.64%1.89B
40.43%5.17B
80.37%4.08B
74.10%2.7B
Cash paid to acquire fixed assets intangible assets and other long-term assets
24.01%279.62M
38.57%209.64M
-28.74%64.25M
14.11%373.99M
-3.03%225.48M
18.27%151.29M
41.01%90.16M
59.02%327.75M
58.30%232.52M
24.14%127.92M
 Net cash paid to acquire subsidiaries and other business units
----
----
----
--130K
----
----
----
----
----
----
Cash paid relating to other investing activities
21.72%5.65B
-11.30%3.23B
-26.02%1.62B
16.75%6.45B
14.53%4.64B
38.20%3.64B
88.07%2.19B
43.00%5.53B
54.21%4.05B
39.13%2.63B
Cash outflows from investing activities
21.83%5.93B
-9.31%3.43B
-26.12%1.69B
16.61%6.83B
13.58%4.87B
37.28%3.79B
85.62%2.28B
43.81%5.86B
54.42%4.29B
38.35%2.76B
Net cash flows from investing activities
-1,678.97%-1.21B
-587.48%-949.08M
-73.76%-673.52M
57.41%-293.39M
66.45%-67.83M
449.37%194.69M
-352.06%-387.61M
-75.51%-688.9M
60.47%-202.19M
87.37%-55.73M
Financing cash flow
Cash received from capital contributions
--98.86M
----
----
----
----
----
----
----
----
----
Cash from borrowing
61.69%64.68M
99.03%49.76M
-20.00%20M
100.00%80M
0.00%40M
0.00%25M
--25M
5.26%40M
5.26%40M
-10.71%25M
Cash inflows from financing activities
308.83%163.53M
99.03%49.76M
-20.00%20M
100.00%80M
0.00%40M
0.00%25M
--25M
5.26%40M
5.26%40M
-10.71%25M
Borrowing repayment
37.67%55.07M
-19.73%20.07M
0.00%10M
14.58%55M
-16.67%40M
-10.71%25M
25.00%10M
26.32%48M
26.32%48M
0.00%28M
Dividend interest payment
58.63%324.23M
60.62%324.94M
178.23%1.28M
-0.06%202.62M
0.92%204.39M
0.03%202.31M
7.26%460.24K
98.18%202.74M
98.67%202.53M
99.12%202.24M
Cash payments relating to other financing activities
125.25%49.94M
9.95%14.54M
22.86%6.77M
8.36%32.55M
-2.28%22.17M
-10.93%13.22M
-31.21%5.51M
19.53%30.04M
46.11%22.69M
65.66%14.85M
Cash outflows from financing activities
61.03%429.23M
49.48%359.55M
13.02%18.05M
3.35%290.17M
-2.44%266.56M
-1.86%240.53M
-2.85%15.97M
69.72%280.78M
75.73%273.21M
76.92%245.09M
Net cash flows from financing activities
-17.28%-265.7M
-43.73%-309.79M
-78.40%1.95M
12.71%-210.17M
2.85%-226.56M
2.07%-215.53M
154.94%9.03M
-88.94%-240.78M
-98.53%-233.21M
-99.12%-220.09M
Net cash flow
Exchange rate change effecting cash and cash equivalents
634.97%213.14K
557.18%177.18K
602.30%129.75K
-54.32%414.76K
121.24%29K
188.12%26.96K
-31.21%18.48K
179.33%907.94K
0.25%-136.52K
73.05%-30.6K
Net increase in cash and cash equivalents
-206.99%-560.94M
-249.87%-636.86M
-2,990.80%-437.86M
845.61%505.15M
156.10%524.29M
255.27%424.93M
-107.70%-14.17M
-137.64%-67.75M
303.99%204.72M
153.53%119.61M
Add:Begin period cash and cash equivalents
33.76%2.01B
33.58%2.01B
33.58%2.01B
-4.31%1.5B
-4.44%1.5B
-4.31%1.5B
-4.31%1.5B
12.93%1.57B
12.93%1.57B
12.93%1.57B
End period cash equivalent
-28.52%1.45B
-28.85%1.37B
5.47%1.57B
33.58%2.01B
14.05%2.03B
14.04%1.93B
-15.14%1.49B
-4.31%1.5B
37.55%1.78B
44.76%1.69B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash 12.01%4.46B11.83%2.89B5.39%1.44B12.78%5.3B17.32%3.98B17.49%2.58B20.51%1.36B12.89%4.7B7.39%3.39B6.88%2.2B
Refunds of taxes and levies 525.40%101.94K245.16%56.26K41.91%19.87K-92.69%21.06K-75.88%16.3K-63.58%16.3K-68.72%14K-66.58%288.22K-92.38%67.57K-84.73%44.76K
Cash received relating to other operating activities 19.66%87.89M17.00%60.79M45.58%28.41M-5.15%92.29M49.48%73.45M55.17%51.95M23.94%19.52M46.39%97.3M83.74%49.14M31.42%33.48M
Cash inflows from operating activities 12.15%4.55B11.94%2.95B5.95%1.47B12.41%5.39B17.77%4.06B18.06%2.63B20.55%1.38B13.40%4.8B8.01%3.44B7.17%2.23B
Goods services cash paid 20.06%1.06B2.77%621.53M15.25%343.92M8.26%1.15B12.25%880.33M19.18%604.75M8.68%298.42M31.81%1.06B1.12%784.29M5.59%507.42M
Staff behalf paid 4.99%765.4M7.35%451.4M11.51%222.22M13.00%940.48M15.61%728.99M22.39%420.48M15.24%199.29M10.89%832.26M19.70%630.55M28.01%343.55M
All taxes paid 10.29%554.69M11.55%397.27M32.63%208.32M24.70%677.63M19.57%502.94M18.86%356.15M34.28%157.07M-0.49%543.39M0.61%420.64M-1.91%299.63M
Cash paid relating to other operating activities 12.06%1.26B6.13%856.2M25.64%458.35M7.85%1.62B16.21%1.12B17.78%806.76M22.69%364.82M5.04%1.5B3.06%967.93M-1.99%684.96M
Cash outflows from operating activities 12.37%3.64B6.32%2.33B20.91%1.23B11.38%4.38B15.47%3.24B19.21%2.19B18.30%1.02B11.53%3.94B5.40%2.8B4.69%1.84B
Net cash flows from operating activities 11.30%911.19M39.51%621.84M-35.90%233.58M17.10%1.01B27.86%818.65M12.72%445.74M27.34%364.4M22.81%861.02M21.11%640.26M20.36%395.46M
Investing cash flow
Cash received from returns on investments 15.24%37.37M-26.35%17.42M-40.80%6.73M30.56%42.25M29.21%32.43M61.03%23.66M136.73%11.36M-6.18%32.36M4.83%25.1M-15.43%14.69M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset 15.04%603.82K-55.76%143.71K----1,532.73%1.48M1,271.31%524.88K--324.88K--189.88K-73.61%90.8K-88.95%38.28K----
Cash received relating to other investing activities -1.70%4.69B-37.65%2.47B-46.60%1.01B26.42%6.49B17.46%4.77B47.23%3.96B65.32%1.88B40.89%5.13B81.22%4.06B75.14%2.69B
Cash inflows from investing activities -1.58%4.72B-37.58%2.49B-46.57%1.01B26.48%6.53B17.54%4.8B47.31%3.98B65.64%1.89B40.43%5.17B80.37%4.08B74.10%2.7B
Cash paid to acquire fixed assets intangible assets and other long-term assets 24.01%279.62M38.57%209.64M-28.74%64.25M14.11%373.99M-3.03%225.48M18.27%151.29M41.01%90.16M59.02%327.75M58.30%232.52M24.14%127.92M
 Net cash paid to acquire subsidiaries and other business units --------------130K------------------------
Cash paid relating to other investing activities 21.72%5.65B-11.30%3.23B-26.02%1.62B16.75%6.45B14.53%4.64B38.20%3.64B88.07%2.19B43.00%5.53B54.21%4.05B39.13%2.63B
Cash outflows from investing activities 21.83%5.93B-9.31%3.43B-26.12%1.69B16.61%6.83B13.58%4.87B37.28%3.79B85.62%2.28B43.81%5.86B54.42%4.29B38.35%2.76B
Net cash flows from investing activities -1,678.97%-1.21B-587.48%-949.08M-73.76%-673.52M57.41%-293.39M66.45%-67.83M449.37%194.69M-352.06%-387.61M-75.51%-688.9M60.47%-202.19M87.37%-55.73M
Financing cash flow
Cash received from capital contributions --98.86M------------------------------------
Cash from borrowing 61.69%64.68M99.03%49.76M-20.00%20M100.00%80M0.00%40M0.00%25M--25M5.26%40M5.26%40M-10.71%25M
Cash inflows from financing activities 308.83%163.53M99.03%49.76M-20.00%20M100.00%80M0.00%40M0.00%25M--25M5.26%40M5.26%40M-10.71%25M
Borrowing repayment 37.67%55.07M-19.73%20.07M0.00%10M14.58%55M-16.67%40M-10.71%25M25.00%10M26.32%48M26.32%48M0.00%28M
Dividend interest payment 58.63%324.23M60.62%324.94M178.23%1.28M-0.06%202.62M0.92%204.39M0.03%202.31M7.26%460.24K98.18%202.74M98.67%202.53M99.12%202.24M
Cash payments relating to other financing activities 125.25%49.94M9.95%14.54M22.86%6.77M8.36%32.55M-2.28%22.17M-10.93%13.22M-31.21%5.51M19.53%30.04M46.11%22.69M65.66%14.85M
Cash outflows from financing activities 61.03%429.23M49.48%359.55M13.02%18.05M3.35%290.17M-2.44%266.56M-1.86%240.53M-2.85%15.97M69.72%280.78M75.73%273.21M76.92%245.09M
Net cash flows from financing activities -17.28%-265.7M-43.73%-309.79M-78.40%1.95M12.71%-210.17M2.85%-226.56M2.07%-215.53M154.94%9.03M-88.94%-240.78M-98.53%-233.21M-99.12%-220.09M
Net cash flow
Exchange rate change effecting cash and cash equivalents 634.97%213.14K557.18%177.18K602.30%129.75K-54.32%414.76K121.24%29K188.12%26.96K-31.21%18.48K179.33%907.94K0.25%-136.52K73.05%-30.6K
Net increase in cash and cash equivalents -206.99%-560.94M-249.87%-636.86M-2,990.80%-437.86M845.61%505.15M156.10%524.29M255.27%424.93M-107.70%-14.17M-137.64%-67.75M303.99%204.72M153.53%119.61M
Add:Begin period cash and cash equivalents 33.76%2.01B33.58%2.01B33.58%2.01B-4.31%1.5B-4.44%1.5B-4.31%1.5B-4.31%1.5B12.93%1.57B12.93%1.57B12.93%1.57B
End period cash equivalent -28.52%1.45B-28.85%1.37B5.47%1.57B33.58%2.01B14.05%2.03B14.04%1.93B-15.14%1.49B-4.31%1.5B37.55%1.78B44.76%1.69B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+0.70%